Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Jun 1, 2018
Clinical News
Gilead's Epclusa approved in China for HCV
Read More
BioCentury
|
May 30, 2018
Company News
Gilead's Epclusa approved in China for HCV
Read More
BioCentury
|
Oct 27, 2017
Company News
Arcturus, JNJ to develop nucleic acids to treat HBV
Read More
BioCentury
|
Oct 6, 2017
Clinical News
Merck discontinues HCV candidates MK-3682B and MK-3682C
Read More
BioCentury
|
Oct 6, 2017
Clinical News
Merck discontinues HCV candidates MK-3682B and MK-3682C
Read More
BioCentury
|
Sep 29, 2017
Clinical News
China approves HCV drugs from Gilead and AbbVie
Read More
BioCentury
|
Sep 29, 2017
Clinical News
Merck discontinues HCV candidates
Read More
BioCentury
|
Sep 26, 2017
Company News
GSK, Gilead, Shire gain RDPAC membership
Read More
BioCentury
|
Sep 25, 2017
Company News
Gilead's Sovaldi gets Chinese approval
Read More
BioCentury
|
Sep 15, 2017
Company News
J&J drops Achillion HCV deal
Read More
Items per page:
10
1 - 10 of 676